Deciphering the path ahead in myelodysplastic syndrome^†

• Pages: 157-158
• First Published: 08 January 2010

Treatment of Philadelphia-positive acute lymphocytic leukemia with tyrosine kinase inhibitors: What is the optimal regimen?^†

• Pages: 158-159
• First Published: 20 January 2010

Host immunity affects survival in myelodysplastic syndromes: Independent prognostic value of the absolute lymphocyte count^†

• Pages: 160-163
• First Published: 22 December 2009

Dasatinib 140 mg once daily versus 70 mg twice daily in patients with Ph-positive acute lymphoblastic leukemia who failed imatinib: Results from a phase 3 study^{† ‡}

• Pages: 164-170
• First Published: 15 December 2009

Systemic AL amyloidosis with acquired factor X deficiency: A study of perioperative bleeding risk and treatment outcomes in 60 patients^†

• Pages: 171-173
• First Published: 01 December 2009

The incidence of immune thrombocytopenic purpura in children and adults: A critical review of published reports^†

• Pages: 174-180
• First Published: 22 December 2009

Unexpected immune hemolytic anemia in an intensive care ward patient^†

• Page: 181
• First Published: 25 August 2009

Fatal bone marrow embolism in a child with hemoglobin SE disease^†

• Pages: 182-184
• First Published: 01 December 2009

Laboratory monitoring of new anticoagulants^†

• Pages: 185-187
• First Published: 04 December 2009

Splenic hyalohyphomycosis, molecularly and immunologically consistent with invasive aspergillosis, in a patient with acute lymphoblastic leukemia^†

• Pages: 188-189
• First Published: 16 April 2009

ASH 2009 meeting report—Top 10 clinically oriented abstracts in myeloproliferative neoplasms^†

• Pages: 190-192
• First Published: 22 December 2009

• Pages: 193-196
• First Published: 23 December 2009

ASH 2009 meeting report—Top 10 clinically oriented abstracts in myelodysplastic syndromes^†

• Pages: 196-201
• First Published: 31 December 2009

ASH 2009 meeting report—Top 10 clinically oriented abstracts in coagulation medicine and platelet disorders^†

• Pages: 202-204
• First Published: 06 January 2010

ASH 2009 meeting report—Top 10 clinically oriented abstracts in sickle cell disease^†

• Pages: 204-206
• First Published: 08 January 2010

ASH 2009 meeting report—Top 10 clinically oriented abstracts in chronic lymphocytic leukemia^†

• Pages: 207-210
• First Published: 08 January 2010

ASH 2009 meeting report—Top 10 clinically oriented abstracts in multiple myeloma^†

• Pages: 210-213
• First Published: 08 January 2010

Genetic polymorphisms in cytochrome P450s, GSTs, NATs, alcohol consumption and risk of non-Hodgkin lymphoma^†

• Pages: 213-215
• First Published: 04 December 2009

Italian travel memoirs of a hematologist's grandson. I. Bologna^†

• Pages: 216-217
• First Published: 22 December 2009

Letter in response to: “Pulmonary thrombi are not detected by 3D magnetic resonance angiography in adults with sickle cell anemia and an elevated triscuspid regurgitant jet velocity”^†

• Page: 217
• First Published: 12 November 2009

Author response letter to: “Pulmonary thrombi are not detected by 3D magnetic resonance angiography in adults with sickle cell anemia and an elevated tricuspid regurgitant jet velocity” ^†

• Pages: 217-218
• First Published: 10 December 2009

Prominent Dutcher body formation in a case of follicular lymphoma with BCL6 gene rearrangement and intact BCL2 gene^†

• Pages: 218-219
• First Published: 10 December 2009

Intrathecal chemotherapy and meningeal relapses in myelomonocytic AML. A single institution experience^†

• Page: 219
• First Published: 01 December 2009

AJH Hematology Crossword Puzzle, March 2010^†‡

• Pages: 220-221
• First Published: 19 February 2010